Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

INR 56.84

(0.0%)

Total Debt Summary of Aarey Drugs & Pharmaceuticals Limited

  • Aarey Drugs & Pharmaceuticals Limited's latest annual total debt in 2023 was 313.52 Million INR , down -16.88% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported annual total debt of 377.18 Million INR in 2022, up 166.32% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported annual total debt of 141.62 Million INR in 2021, down -21.39% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported quarterly total debt of - INR for 2023 Q1, down -100.0% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported quarterly total debt of 313.52 Million INR for 2023 FY, down -16.88% from previous quarter.

Annual Total Debt Chart of Aarey Drugs & Pharmaceuticals Limited (2023 - 2008)

Historical Annual Total Debt of Aarey Drugs & Pharmaceuticals Limited (2023 - 2008)

Year Total Debt Total Debt Growth
2023 313.52 Million INR -16.88%
2022 377.18 Million INR 166.32%
2021 141.62 Million INR -21.39%
2020 180.17 Million INR 0.72%
2019 178.87 Million INR 10.72%
2018 161.55 Million INR 399.24%
2017 32.35 Million INR -68.86%
2016 103.92 Million INR -28.5%
2015 145.35 Million INR 31.9%
2014 110.19 Million INR 92.8%
2013 57.15 Million INR 17.59%
2012 48.6 Million INR 9.7%
2011 44.3 Million INR 34.5%
2010 32.94 Million INR -28.92%
2009 46.34 Million INR 208.31%
2008 15.03 Million INR 0.0%

Peer Total Debt Comparison of Aarey Drugs & Pharmaceuticals Limited

Name Total Debt Total Debt Difference
Sigachi Industries Limited 1.43 Billion INR 78.083%
Ind-Swift Limited 10.13 Billion INR 96.908%
Bajaj HealthCare Limited 3.32 Billion INR 90.58%
Sakar Healthcare Limited 793.51 Million INR 60.489%
Aurobindo Pharma Limited 66.47 Billion INR 99.528%
Innova Captab Limited 2.45 Billion INR 87.209%
Divi's Laboratories Limited 30 Million INR -945.077%
AstraZeneca Pharma India Limited 45.98 Million INR -581.839%
Morepen Laboratories Limited 289.99 Million INR -8.114%
Mankind Pharma Limited 2.07 Billion INR 84.867%
Sequent Scientific Limited 4.87 Billion INR 93.571%
Wanbury Limited 1.16 Billion INR 73.085%
Laurus Labs Limited 25.77 Billion INR 98.784%
Nectar Lifesciences Limited 6.35 Billion INR 95.067%
Glenmark Life Sciences Limited 171.48 Million INR -82.834%
Alembic Limited 91.5 Million INR -242.648%
Hikal Limited 8.17 Billion INR 96.165%
Alembic Pharmaceuticals Limited 5.13 Billion INR 93.89%
Neuland Laboratories Limited 953.89 Million INR 67.132%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 91.698%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 97.453%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 4.297%
Themis Medicare Limited 957.92 Million INR 67.271%
RPG Life Sciences Limited - INR -Infinity%
Zydus Lifesciences Limited 8.04 Billion INR 96.101%
Lupin Limited 29.21 Billion INR 98.927%
Amrutanjan Health Care Limited 17.28 Million INR -1714.055%
Wockhardt Limited 23.56 Billion INR 98.669%
Vaishali Pharma Limited 134.91 Million INR -132.38%
Aarti Pharmalabs Limited 2.85 Billion INR 89.009%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR -250.658%
Jubilant Pharmova Limited 36.64 Billion INR 99.144%
FDC Limited 205.18 Million INR -52.8%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 98.434%
Kilitch Drugs (India) Limited 316.46 Million INR 0.93%
Eris Lifesciences Limited 27.81 Billion INR 98.873%
Venus Remedies Limited 413.3 Million INR 24.142%
ZIM Laboratories Limited 1.08 Billion INR 71.19%
Bliss GVS Pharma Limited 998.4 Million INR 68.597%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 19.7 Million INR -1491.488%
Shilpa Medicare Limited 9.37 Billion INR 96.655%
Albert David Limited 33.24 Million INR -843.153%
Ajanta Pharma Limited 352.8 Million INR 11.133%
Hester Biosciences Limited 2.44 Billion INR 87.171%
Suven Pharmaceuticals Limited 649.96 Million INR 51.763%
Solara Active Pharma Sciences Limited 10.11 Billion INR 96.9%
Gufic Biosciences Limited 3.32 Billion INR 90.583%
Windlas Biotech Limited 36.41 Million INR -761.091%
Procter & Gamble Health Limited 95.6 Million INR -227.953%
Mangalam Drugs & Organics Limited 984.92 Million INR 68.168%
Granules India Limited 13.15 Billion INR 97.616%
Aarti Drugs Limited 5.64 Billion INR 94.444%
Bal Pharma Limited 1.39 Billion INR 77.549%
Alkem Laboratories Limited 14.18 Billion INR 97.79%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.042%
Lincoln Pharmaceuticals Limited 10.66 Million INR -2838.911%
Medicamen Biotech Limited 308.17 Million INR -1.736%
Unichem Laboratories Limited 2.47 Billion INR 87.333%
Bafna Pharmaceuticals Limited 243.89 Million INR -28.549%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -7043.383%
Valiant Laboratories Limited 767.08 Million INR 59.128%
Orchid Pharma Limited 1.35 Billion INR 76.807%
Medico Remedies Limited 80.5 Million INR -289.45%
Ind-Swift Laboratories Limited 166.21 Million INR -88.624%
Ipca Laboratories Limited 14.38 Billion INR 97.82%
Brooks Laboratories Limited 56.41 Million INR -455.705%
Syncom Formulations (India) Limited 724.86 Million INR 56.747%
Piramal Enterprises Limited 535.85 Billion INR 99.941%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.22%
NATCO Pharma Limited 3.71 Billion INR 91.554%
Suven Life Sciences Limited 7.09 Million INR -4317.685%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 83.791%
Strides Pharma Science Limited 25.16 Billion INR 98.754%
Indoco Remedies Limited 6.71 Billion INR 95.334%
Alpa Laboratories Limited 52.46 Million INR -497.585%
Lasa Supergenerics Limited 220.76 Million INR -42.019%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 48.729%